BMS Ascends To In Vivo CAR-T Market With Orbital Buy

 
• By Alaric DeArment
  
M&A
BMS is moving to buy in vivo CAR-T developer Orbital Therapeutics. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business